< Back to previous page
Researcher
Johan Neyts
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Faculty of Medicine (Faculty)
Member
From1 Oct 2000 → 30 Sep 2002 - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Infrastructure
1 - 1 of 1
Projects
21 - 30 of 82
- Prohylaxis of at risks persons with an ultrapotent SARS-CoV-2 neutralizing antibody.From20 May 2020 → 21 May 2021Funding: FWO thematic call for applied research
- Intravital microscopy platform for infectious and inflammatory diseasesFrom1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- CARE Corona Accelerated R&D in EuropeFrom1 Apr 2020 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- A promising COVID-19 vaccine candidate.From1 Apr 2020 → 31 Mar 2021Funding: BOF - various
- EXaSCale smArt pLatform Against paThogEns for Corona VirusFrom1 Apr 2020 → 30 Sep 2021Funding: H2020-EU.3.2. - SOCIETAL CHALLENGES - Food security, sustainable agriculture, marine and maritime research and the bio-economy
- CoVAX-PreC – Preclinical evaluation of a potent COVID-19 vaccine candidate toward an accelerated clinical developmentFrom1 Apr 2020 → 30 Jun 2021Funding: IOF - technology validation in lab
- Swift COronavirus therapeutics REsponseFrom1 Apr 2020 → 30 Sep 2022Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- COVID19:HTS-kernFrom25 Mar 2020 → 30 Jun 2022Funding: Foreign private sponsor - undefined
- Mapping the druggable genome/anti-virome of neglected & emerging RNA viruses using a strategy based on multicolor/multiplex high-content imaging, in vitro evolution and chemogenomicsFrom1 Mar 2020 → 28 Feb 2021Funding: BOF - postdoctoral mandates
- In vivo proof-of-concept for the efficacy of YF/HBc, a novel therapeutic hepatitis B vaccine candidateFrom1 Jan 2020 → 31 Dec 2021Funding: IOF - technology validation in lab
Publications
1 - 10 of 621
- Mechanism of action of phthalazinone derivatives against rabies virus.(2024)
Authors: Dirk Jochmans, Johan Neyts
Pages: 105838 - Design, synthesis, and molecular modeling studies of novel 2-quinolone-1,2,3-triazole-α-aminophosphonates hybrids as dual antiviral and antibacterial agents.(2024)
Authors: Johan Neyts, Dirk Jochmans, Steven De Jonghe
Pages: 116235 - Beware of drug resistance: Let's not lose tecovirimat against mpox.(2024)
Authors: Johan Neyts, Laurens Liesenborghs
Pages: 276 - 278 - Molnupiravir inhibits human norovirus and rotavirus replication in 3D human intestinal enteroids.(2024)
Authors: Johan Neyts, Jelle Matthijnssens, Joana Duarte Da Rocha Pereira
Pages: 105839 - Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study.(2024)
Authors: Simon Feys, Sam Vanmassenhove, Bram Boeckx, Seppe Cambier, Yves Debaveye, Greet Hermans, Katrien Lagrou, Johan Neyts, Marijke Peetermans, Joana Duarte Da Rocha Pereira, et al.
Pages: e247 - e260 - Discovery of JNJ-1802, a First-in-Class Pan-Serotype Dengue Virus NS4B Inhibitor(2024)
Authors: Suzanne Kaptein, Johan Neyts
Pages: 4063 - 4082 - Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted(2024)
Authors: Dirk Jochmans, Rana Abdelnabi, Birgit Weynand, Johan Neyts
- Studies of the human-to-human spread of respiratory pathogens.(2024)
Authors: Emmanuel Andre, Johan Neyts
- Genetic consequences of effective and suboptimal dosing with mutagenic drugs in a hamster model of SARS-CoV-2 infection(2024)
Authors: Rana Abdelnabi, Johan Neyts
- Design, synthesis, and lead optimization of piperazinyl-pyrimidine analogues as potent small molecules targeting the viral capping machinery of Chikungunya virus(2024)
Authors: Rana Abdelnabi, Johan Neyts, Leen Delang
Patents
1 - 10 of 10
- Corona virus binders (Inventor)
- Lassavirus vaccines (Inventor)
- Chimeric filovirus vaccines (Inventor)
- Chimeric zika-japanese encephalitis virus (Inventor)
- Chimeric yellow fever zika virus strain (Inventor)
- Viral replication inhibitors (Inventor)
- Treatment and prevention of dengue disease (Inventor)
- Coronavirus vaccines (Inventor)
- Design synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity (Inventor)
- Treatment and prevention of dengue disease (Inventor)